Kaltenecker, D. ; Schmidt, S.F. ; Weber, P. ; Loft, A. ; Morigny, P. ; Machado, J. ; Geppert, J. ; Saul, K.B.* ; Benedikt-Kühnast, P. ; Molocea, C.-E. ; Scott, R.* ; Haase, K.* ; Martignoni, M.E.* ; Alfaro, A.J. ; Chow, K.K. ; Simoes Fernandez, E. ; Pinhata Otoch, J.* ; Lima, J.D.C.C.* ; Swanton, C.* ; Spielmann, N. ; Hrabě de Angelis, M. ; Elsner, M. ; Ertürk, A. ; Dyar, K.A. ; Rohm, M. ; Prokopchuk, O.* ; Jamal-Hanjani, M.* ; Seelaender, M.* ; Backs, J.* ; Herzig, S. ; Berriel Diaz, M.
Functional liver genomics identifies hepatokines promoting wasting in cancer cachexia.
Cell 188, 4549-4566.e22 (2025)
In cancer cachexia, the presence of a tumor triggers systemic metabolic disruption that leads to involuntary body weight loss and accelerated mortality in affected patients. Here, we conducted transcriptomic and epigenomic profiling of the liver in various weight-stable cancer and cancer cachexia models. An integrative multilevel analysis approach identified a distinct gene expression signature that included hepatocyte-secreted factors and the circadian clock component REV-ERBα as key modulator of hepatic transcriptional reprogramming in cancer cachexia. Notably, hepatocyte-specific genetic reconstitution of REV-ERBα in cachexia ameliorated peripheral tissue wasting. This improvement was associated with decreased levels of specific cachexia-controlled hepatocyte-secreted factors. These hepatokines promoted catabolism in multiple cell types and were elevated in cachectic cancer patients. Our findings reveal a mechanism by which the liver contributes to peripheral tissue wasting in cancer cachexia, offering perspectives for future therapeutic interventions.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Intact ; Rev-erb ; Adipose Tissue Wasting ; Cachexia ; Circadian Clock ; Hepatic Reprogramming ; Liver-secreted Factors ; Muscle Atrophy; Rev-erb-alpha; Gene-expression; Lung-cancer; Transcription; Metabolism; Dysfunction; Mediators; Evolution; Impact; Model
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2025
Prepublished im Jahr
0
HGF-Berichtsjahr
2025
ISSN (print) / ISBN
0092-8674
e-ISSN
1097-4172
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 188,
Heft: 17,
Seiten: 4549-4566.e22
Artikelnummer: ,
Supplement: ,
Reihe
Verlag
Cell Press
Verlagsort
Cambridge, Mass.
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
90000 - German Center for Diabetes Research
30201 - Metabolic Health
30205 - Bioengineering and Digital Health
Forschungsfeld(er)
Helmholtz Diabetes Center
Genetics and Epidemiology
Enabling and Novel Technologies
PSP-Element(e)
G-501900-253
G-501900-251
G-501900-257
G-500692-001
G-500600-001
G-505800-001
G-502594-001
Förderungen
NIHR University College London Hospitals Biomedical Research Centre
Cancer Research UK
UCL Cancer Trials Centre
CRUK
CANCAN Cancer Grand Challenges partnership - Cancer Research UK
NIH National Cancer Institute
CRUK Career Establishment Awardee
NIH National Cancer Institute, IASLC International Lung Cancer Foundation, Lung Cancer Research Foundation
Rosetrees Trust
University College London
Copyright
Erfassungsdatum
2025-07-25